Publikationen (17) Publikationen, an denen Forscher/innen teilgenommen haben

1997

  1. Addition of lamivudine to the drug regimen in patients with advanced HIV disease on nucleoside therapy [4]

    European Journal of Clinical Microbiology and Infectious Diseases

  2. Chemokine receptors and HIV-2 [11]

    AIDS

  3. Co-infection with several HCV genotypes enhances liver damage in patients with chronic hepatitis C [3]

    Journal of Infection

  4. Comparison of three different commercial methods for quantification of plasma HIV RNA in clinical specimens.

    Antiviral therapy

  5. Cuantificación de la viremia por VIH.

    Medicina clínica

  6. Epidemiología de las hepatitis víricas.

    Revista clínica española

  7. Evidence of HIV-2 infection in Equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus

    AIDS Research and Human Retroviruses

  8. Genetic analysis of an HIV type 2 subtype B virus from a spanish individual with AIDS

    AIDS Research and Human Retroviruses

  9. Infección por HTLV-1 en un paciente recluso: primer caso en España.

    Medicina clínica

  10. Lack of antiretroviral effect of alpha-interferon in HIV-infected patients treated for chronic hepatitis C [2]

    Journal of Infection

  11. Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy [10]

    AIDS

  12. Outcome in a cohort of long-term non-progressors in Madrid: virological and immunological findings.

    AIDS (London, England)

  13. Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy [13]

    AIDS

  14. Resistencia a los farmacos antirretrovirales

    Medicina Clinica

  15. Rising incidence of human T-cell leukaemia/lymphoma virus type II in Spanish drug users [12]

    AIDS

  16. Safety and efficacy of two different triple drug combinations in which either lamivudine or didanosine were administered with stavudine plus indinavir [9]

    AIDS

  17. Short-term response to indinavir in patients with advanced HIV disease with prior heavy exposure to nucleoside analogues [7]

    AIDS